Shad Diagnostics

Shad Diagnostics is an innovative biotechnology startup dedicated to developing rapid, non-invasive diagnostic tools for early detection of neurological and vascular disorders such as Alzheimer’s disease and stroke. Using saliva-based biosensors and wearable technology, Shad Diagnostics translates cutting-edge neuroscience into practical, point-of-care solutions.

Founded by Professor Kaneez Fatima-Shad, the company integrates decades of research on neurochemical biomarkers like D-serine to enable early intervention and personalised health monitoring. Shad Diagnostics aims to revolutionize brain health diagnostics through precision, accessibility, and affordability – bridging the gap between laboratory discovery and real-world medical application to improve patient outcomes globally.

Want to learn more or chat with the team? Reach out to Shad Diagnostics team leader, Professor Kaneez Fatima via Shad kaneez.fatima-shad@uts.edu.au

If you would like an introduction – we’re here to help! Contact the ON team via on@csiro.au.